AETHLON MEDICAL, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
AETHLON MEDICAL, INC. (AEMD) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $2.44 million as of 2026-03-31, per its 10-K filed 2026-06-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2026-06-10
- 2026-03-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $2.44M.
- 2025-03-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $415.00K.
- 2024-03-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $2.24M.
- 2023-03-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $1.90M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits |
|---|---|
| 2026-03-31 | $2.44M 10-K · filed 2026-06-10 |
| 2025-03-31 | $415.00K 10-K · filed 2026-06-10 |
| 2024-03-31 | $2.24M 10-K · filed 2025-06-26 |
| 2023-03-31 | $1.90M 10-K · filed 2024-06-27 |
| 2022-03-31 | $1.61M 10-K · filed 2023-06-28 |
| 2021-03-31 | $1.40M 10-K · filed 2022-06-28 |
| 2020-03-31 | $1.18M 10-K · filed 2021-06-24 |
| 2019-03-31 | $944.00K 10-K · filed 2020-06-25 |
| 2018-03-31 | $575.00K 10-K · filed 2019-07-01 |
| 2017-03-31 | $318.00K 10-K · filed 2018-06-08 |
| 2016-03-31 | $0.00 10-K · filed 2017-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |